FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Global approvals · expansion Widening overseas sales through a US home-test clearance and public supply contracts in Brazil.

  • US FDA 510(k) clearance of its COVID-19 home test. Source

Roles often seen at this stageRegulatory affairs · Manufacturing & MSAT · Sales & marketing

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

GenBody

A maker of rapid tests for infectious diseases and drugs, widening overseas sales with a US home-test clearance and public supply in Brazil.

GenBody COVID-19 Ag Home Test

Approved

COVID-19 home antigen test cleared under US FDA 510(k).

HIV/Syphilis combo test

Marketed

Test that checks HIV and syphilis together within 20 minutes, with an additional 8.4 million tests for a Brazilian public institute.

Completion reported

Its COVID-19 home test received full US FDA clearance.

Official role guide

GenBody careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 2

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 젠바디, 코로나19 자가진단 키트 美 FDA 정식 허가 ↗뉴스핌 · Published 2026-03-17 · Sources checked 2026-11-15 · Original unavailable
  2. 젠바디, 브라질에 HIV·매독 진단키트 840만 테스트 추가 공급 ↗EBN · Published Date unconfirmed · Sources checked 2026-11-15 · Original unavailable